admin

The National Medicines Record: What the 2026 Reforms Mean for Australian GPs

Recent federal reforms mark a significant shift in Australian digital health governance with the introduction of a National Medicines Record (NMR). This guide explores how mandatory reporting will centralise prescribing data, mitigate risks from fragmented telehealth services, and enhance clinical oversight for General Practitioners.

The National Medicines Record: What the 2026 Reforms Mean for Australian GPs Read More »

PBS Update: Semaglutide (Wegovy) Recommended for Cardiovascular Risk in Obesity

The PBAC has recommended the PBS listing of semaglutide 2.4 mg for patients with established cardiovascular disease and severe obesity. This article outlines the specific eligibility criteria, including BMI thresholds and ethnicity adjustments, and examines the administrative implications for Australian general practice.

PBS Update: Semaglutide (Wegovy) Recommended for Cardiovascular Risk in Obesity Read More »

What to Expect When Starting GP Training

Transitioning from the structured environment of hospital residency to the autonomy of community general practice represents a profound professional shift. This article explores the critical mindset changes required, the realities of the business of medicine, and practical strategies for managing the unique pressures of the Australian General Practice Training (AGPT) program.

What to Expect When Starting GP Training Read More »

Navigating Menopause Care: New Women’s Health MBS Items Explained

Navigating menopause in general practice presents unique challenges and opportunities. With new MBS items rolling out and a renewed focus on comprehensive, patient-centered care, GPs are better equipped to support women through this vital life stage. This article explores the evolving landscape of menopause assessment and management for Australian practitioners.

Navigating Menopause Care: New Women’s Health MBS Items Explained Read More »